Dow Down1.13% Nasdaq Down1.15%

Rosetta Genomics, Ltd. (ROSG)

-NasdaqCM
3.44 Down 0.07(1.99%) 12:22PM EDT - Nasdaq Real Time Price
Income StatementGet Income Statement for:
View: Annual Data | Quarterly DataAll numbers in thousands
Period EndingDec 31, 2013Dec 31, 2012Dec 31, 2011
Total Revenue 405   201   103  
Cost of Revenue709  258  324  
Gross Profit (304) (57) (221)
Operating Expenses
Research Development1,744  1,247  3,386  
Selling General and Administrative11,299  6,963  5,170  
Non Recurring -   -   -  
Others -   -   -  
Total Operating Expenses -   -   -  
Operating Income or Loss (13,347) (8,267) (8,777)
Income from Continuing Operations
Total Other Income/Expenses Net -   -   -  
Earnings Before Interest And Taxes(13,170)(10,696)(7,393)
Interest Expense -   -   -  
Income Before Tax(13,170)(10,696)(7,393)
Income Tax Expense -   -   -  
Minority Interest -   -   -  
Net Income From Continuing Ops(13,170)(10,696)(7,393)
Non-recurring Events
Discontinued Operations273  239  (1,437)
Extraordinary Items -   -   -  
Effect Of Accounting Changes -   -   -  
Other Items -   -   -  
Net Income (12,897) (10,457) (8,830)
Preferred Stock And Other Adjustments -   -   -  
Net Income Applicable To Common Shares (12,897) (10,457) (8,830)

Sign Up for a Free Trial to EDGAR Online Premium!
Get the critical business and financial information you need for more than 15,000 U.S. public companies.
Sign Up Now - Learn More

Currency in USD.